About lemaitre vascular inc - LMAT
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.
LMAT At a Glance
LeMaitre Vascular, Inc.
63 Second Avenue
Burlington, Massachusetts 01803
| Phone | 1-781-221-2266 | Revenue | 249.60M | |
| Industry | Medical Specialties | Net Income | 57.73M | |
| Sector | Health Technology | 2025 Sales Growth | 13.526% | |
| Fiscal Year-end | 12 / 2026 | Employees | 655 | |
| View SEC Filings |
LMAT Valuation
| P/E Current | 28.739 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 32.208 |
| Price to Sales Ratio | 7.45 |
| Price to Book Ratio | 4.693 |
| Price to Cash Flow Ratio | 22.89 |
| Enterprise Value to EBITDA | 21.525 |
| Enterprise Value to Sales | 6.755 |
| Total Debt to Enterprise Value | 0.11 |
LMAT Efficiency
| Revenue/Employee | 381,071.756 |
| Income Per Employee | 88,143.511 |
| Receivables Turnover | 7.426 |
| Total Asset Turnover | 0.428 |
LMAT Liquidity
| Current Ratio | 12.556 |
| Quick Ratio | 10.952 |
| Cash Ratio | 9.887 |
LMAT Profitability
| Gross Margin | 69.268 |
| Operating Margin | 27.208 |
| Pretax Margin | 30.122 |
| Net Margin | 23.13 |
| Return on Assets | 9.89 |
| Return on Equity | 15.80 |
| Return on Total Capital | 9.969 |
| Return on Invested Capital | 10.531 |
LMAT Capital Structure
| Total Debt to Total Equity | 47.163 |
| Total Debt to Total Capital | 32.048 |
| Total Debt to Total Assets | 30.144 |
| Long-Term Debt to Equity | 46.414 |
| Long-Term Debt to Total Capital | 31.54 |